Muscle atrophy in muscle-specific tyrosine kinase (MuSK)-related myasthenia gravis

Journal of Clinical Neuroscience

Volumn 18, Issue 9, 2011, Pages 1274-1275

  Moon, So Young ^a   Lee, Sang Soo ^a   Hong, Yoon Ho ^b  

^a Chungbuk National University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Muscle atrophy; Muscle specific tyrosine kinase; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; ENZYME ANTIBODY; IMMUNOGLOBULIN; MUSCLE SPECIFIC TYROSINE KINASE; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; NEOSTIGMINE; PREDNISOLONE; PROTEIN TYROSINE KINASE; PYRIDOSTIGMINE; UNCLASSIFIED DRUG;

ADULT; ANTICHOLINERGIC SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; ENDOTRACHEAL INTUBATION; EYE DISEASE; FACE MUSCLE; FEMALE; HUMAN; MUSCLE ACTION POTENTIAL; MUSCLE ATROPHY; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEUROLOGIC EXAMINATION; OPHTHALMOPLEGIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PTOSIS; RESPIRATORY FAILURE; TONGUE; WEIGHT REDUCTION;

ADULT; FEMALE; HUMANS; MUSCULAR ATROPHY; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC;

EID: 79961004248     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2011.01.010     Document Type: Article

References (8)

1. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357:2122-8. (Pubitemid 32607461)
2. Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126:2304-11. (Pubitemid 37432373)
3. Lavrnic D, Losen M, Vujic A, et al. The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 2005;76:1099-102. (Pubitemid 41081284)
4. Farrugia ME, Robson MD, Clover L, et al. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain 2006;129:1481-92. (Pubitemid 43999381)
5. Liyanage Y, Hoch W, Beeson D, et al. The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction. Muscle Nerve 2002;25:4-16. (Pubitemid 34019729)
6. Lecker SH, Jagoe RT, Gilbert A, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004;18:39-51. (Pubitemid 38076464)
7. Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004;117:399-412. (Pubitemid 38534545)
8. Benveniste O, Jacobson L, Farrugia ME, et al. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo. J Neuroimmunol 2005;170:41-8. (Pubitemid 41740905)